The European Bank for Reconstruction and Development (EBRD) has approved a $25 mln loan for Uzbek pharmaceutical company and medicine distributor Meros Pharm, according to a statement from the bank’s press service.
The company plans to use the loan to expand its warehouse infrastructure, which will enable Meros Pharm to manage supply during periods of peak demand better and reduce delivery times.
The EBRD noted that this financing will also contribute to greater transparency in Uzbekistan’s pharmaceutical sector and improve access to high-quality medicines for people in the country’s regions.
To date, the EBRD’s total investments in Uzbekistan have reached €5.6 bn, with the majority directed toward supporting the private sector.
Kursiv Uzbekistan also reports that Uzbekistan and Russia plan to train pharmaceutical professionals jointly.
